Uncontrolled asthma Case report

Abstract

Asthma is one of the most common chronic respiratory diseases, with global importance and serious public health implications. It is a chronic disease, underlying the inflammatory process in the respiratory tract, resulting in bronchial muscular contraction, thickening of the airway wall and increased secretion of mucus. The effects of asthma affect the lives of patients, limiting their life and work activity, reducing the quality of life. They can also lead to severe exacerbations and sudden death. The author presents the case of a 39-year-old man with moderate, poorly controlled asthma. The patient had a tiring, choking cough, difficult exhalation, and sometimes chest tightness. The symptoms mainly occurred at night and woke him up from sleep. His main health problem was non-compliance and the misapplication of emergency medications. The rapid and excellent improvement after the acute use of short acting beta agonists caused the patient to downplay the disease, saw no need for chronic medication, and limited asthma treatment to rescue medication. The proposed treatment with a combined formulation (budesonide with formoterol) in one inhaler resulted in the relief of symptoms and control of the disease. The use of a modern Forspiro® dry powder inhaler additionally contributed to the patient’s compliance. The possibility of using a combination of two drugs – glucocorticosteroids and β2-agonists from the same inhaler, according to the patient’s needs, is an early intervention that most effectively prevents exacerbations. There is increasing evidence that the anti-inflammatory reliever strategy is more effective than other strategies with short acting beta agonists in controlling asthma and reducing flare-ups at all levels of asthma severity.